Introduction
Glomerulonephritis - Overview
Glomerulonephritis - Therapeutics Development
Glomerulonephritis - Therapeutics Assessment
Glomerulonephritis - Companies Involved in Therapeutics Development
Glomerulonephritis - Drug Profiles
Glomerulonephritis - Dormant Projects
Glomerulonephritis - Discontinued Products
Glomerulonephritis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Glomerulonephritis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Glomerulonephritis - Pipeline by Aduro BioTech Inc, H1 2020
Glomerulonephritis - Pipeline by Alexion Pharmaceuticals Inc, H1 2020
Glomerulonephritis - Pipeline by Algomedix Inc, H1 2020
Glomerulonephritis - Pipeline by Alnylam Pharmaceuticals Inc, H1 2020
Glomerulonephritis - Pipeline by Amyndas Pharmaceuticals LLC, H1 2020
Glomerulonephritis - Pipeline by Angion Biomedica Corp, H1 2020
Glomerulonephritis - Pipeline by Apellis Pharmaceuticals Inc, H1 2020
Glomerulonephritis - Pipeline by Aravive Inc, H1 2020
Glomerulonephritis - Pipeline by Aurinia Pharmaceuticals Inc, H1 2020
Glomerulonephritis - Pipeline by Biogen Inc, H1 2020
Glomerulonephritis - Pipeline by Bristol-Myers Squibb Co, H1 2020
Glomerulonephritis - Dormant Projects, H1 2020
Glomerulonephritis - Dormant Projects, H1 2020 (Contd..1), H1 2020
Glomerulonephritis - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Glomerulonephritis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• Aduro BioTech Inc
• Alexion Pharmaceuticals Inc
• Algomedix Inc
• Alnylam Pharmaceuticals Inc
• Amyndas Pharmaceuticals LLC
• Angion Biomedica Corp
• Apellis Pharmaceuticals Inc
• Aravive Inc
• Aurinia Pharmaceuticals Inc
• Biogen Inc
• Bristol-Myers Squibb Co
• Calliditas Therapeutics AB
• Cellmid Ltd
• Certa Therapeutics Pty Ltd
• ChemoCentryx Inc
• Coegin Pharma AS
• Complexa Inc
• Cytodesign Inc
• Dimerix Ltd
• Ergon Pharmaceuticals LLC
• Goldfinch Biopharma Inc
• HanAll Biopharma Co Ltd
• Integral Molecular Inc
• INVENT Pharmaceuticals Inc
• Ionis Pharmaceuticals Inc
• Kyowa Kirin Co Ltd
• Mallinckrodt Plc
• Merck KGaA
• MorphoSys AG
• Novartis AG
• NovelMed Therapeutics Inc
• Omeros Corp
• Oraxion Therapeutics Inc
• Pfizer Inc
• Polyneuron Pharmaceuticals AG
• Ra Pharmaceuticals Inc
• Reata Pharmaceuticals Inc
• RemeGen Ltd
• Retrophin Inc
• Sujana Biotech, LLC
• Takeda Pharmaceutical Co Ltd
• Vertex Pharmaceuticals Inc
• Visterra Inc
• ZyVersa Therapeutics Inc